Topics

Companies Related to "Amgen says Kyprolis Darzalex combination hits main goal" [Most Relevant Company Matches] [Search Results] RSS

13:08 EST 17th November 2019 | BioPortfolio

Here are the most relevant search results for "Amgen says Kyprolis Darzalex combination hits main goal" found in our extensive corporate database of over 50,000 company records.

Showing "Amgen says Kyprolis Darzalex combination hits main goal" Companies 1–25 of 1,500+

Relevant

HITS, Inc.

HITS, Inc. is a special events management company primarily focused on producing endurance sports events and hunter/jumper horse shows. Based in upstate New York in the village of Saugerties, HITS is dedicated to creating high-quality events in desirable destinations with unmatched, professional operations. For more information about the HITS Triathlon Ser...


Amgen Inc.

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight agai...

Amgen, Inc.

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight agai...


Amgen

The Amgen Foundation (www.amgen.com/citizenship/overview.html) seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. Since 1991, the Foundation has made $140 million in grants to nonprofit organizations throughout the United States, Puerto Rico and Europe that impact society in inspiring and innovative wa...

Amgen AB

Amgen är ett världsledande bioteknologiskt läkemedelsföretag. Genom vetenskapliga upptäckter och innovationer har företaget under 25 års tid bidragit till att radikalt förbättra människors liv. Amgen är föregångare i utvecklingen av nya produkter baserade på rekombinant DNA-teknik och molekylärbiologi och stod för lanseringen av bioteknikindustrins första storsäljande läkemedel....

Amgen Inc

Amgen is a leading human therapeutics company in the biotechnology industry. For 25 years, the company has tapped the power of scientific discovery and innovation to dramatically improve people’s lives.Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fo...

SymBio Pharmaceuticals Limited

SymBio Pharmaceuticals Limited was established in March, 2005 by Fuminori Yoshida who previously served concurrently as Corporate VP of Amgen Inc. and founding President of Amgen Japan. In May, 2016 SymBio incorporated its wholly-owned subsidiary in the U.S., SymBio Pharma USA, Inc. (Headquarters: Menlo Park, California, President: Mr. Fuminori Yoshida). S...

Amgen Incorporated

Over the past quarter century, Amgen has pioneered the methods by which human proteins that play a role in disease processes are identified, isolated, produced in quantity and used as therapeutics. Today, Amgenhas research programs in inflammation, metabolic disorders and osteoporosis, neurology, oncology and hematology. The company has R&D facilities in Thousand Oaks, CA; San Francisco, CA; Cambr...

Main Drug Mart.

Mr. Souren Agemian, founder and president of Main Drug Mart, has laboured very diligently since 1968 to acquire the trust and confidence of his patients. As such, Main Drug Mart's reputation was quickly built as an organization committed to superior pharmaceutical care and service. With his continuous enthusiasm and support, the Main Drug Mart group was established and grew to include a number of,...

Hanmi Pharmaceutical co., Ltd.

Hanmi Pharmaceutical is a Korea-based pharmaceutical company. The Company invests over 20 percent of its sales in R&D and has over 20 programs consisting of the novel long acting biologics including weekly Insulin, weekly to monthly GLP-1, and their combination for diabetes and obesity (collectively referred as Quantum Project), the novel targeted anti-can...

SU2C/Amgen

Community Health Alliance, Inc. (CHA)

For more information on the Commonwealth’s HIE Strategic and Operational Plans for Statewide HIE please visit www.hits.virginia.gov.

X-BODY BioSciences

X-BODY BioSciences was founded in 2008 by Richard Wagner, Ph.D., Gordon Binder, and Brant Binder, MBA. Dr. Wagner previously co-developed the fibronectin domain antibody-mimetic platform at Phylos, later acquired by Bristol Myers Squibb, and the DirectSelect small molecule library screening system at Praecis Pharmaceuticals, acquired by GlaxoSmithKline in 2007. Mr. Gordon Binder is the former C...

Carbylan BioSurgery, Inc.

Carbylan (www.carbylan.com) was founded in 2005 to develop and market medical devices and device/drug combination products based on novel chemically engineered polymer systems incorporating hyaluronic acid, a well-known polysaccharide widely present in the human body. Its initial market focus is therapeutic medical devices and combination products to treat...

Model N, Inc.

Model N is the leader in Revenue Management solutions. Model N helps our customers dramatically improve pricing and contracting, rebates and incentives, and sales and marketing performance analysis to increase their revenue. Model N drives improved pricing, margin, and revenue performance for our customers through a powerful combination of best practices, ...

The Main Street America Group

With roots dating back to 1923, The Main Street America Group is a super regional insurance company which writes business through nine property/casualty insurance carriers: NGM Insurance Company, Old Dominion Insurance Company, Main Street America Assurance Company, MSA Insurance Company, Great Lakes Casualty Insurance Company Grain Dealers Mutual Insuranc...

Quantum Pharmaceuticals Ltd.

QuantumLead™ is a collaborative global project of InterBioScreen and Quantum Pharmaceuticals. This new project unites Quantum Pharmaceuticals’ next generation in silico lead optimization technology, with InterBioScreen’s unique collection of synthetic and natural compound libraries and network of more than 1500 highly qualified chemists throughout Russia and the CIS./p> The main goals of the...

Probably Relevant

MEDI TALENT GROUP

Based on the theories of Chinese traditional and Western medicine, combining with modern medical and bioengineering techniques, MEDITALENT GROUP is engaged to be the Character of?Modernization of Chinese Traditional Medicine? - Gene engineering and cell engineering techniques. Our Main Goal is to develop continuously the modernized natural herbal preparation those are safe & convenient to use, and...

CryoLogic

CryoLogic Pty. Ltd. is an Australian company dedicated to providing innovative solutions to Instrumentation, Measurement and Control problems in Medical, Veterinary and Biological Sciences. Its goal is to deliver functional, reliable, and affordable equipment. CryoLogic provides a customisation service, develops new products in consultation with clients, and undertakes research and development. Ou...

Mediktor

Mediktor’s goal is to provide health insurance companies with a tool to help manage their member base. Mediktor has a multidisciplinary team of health professionals, computer scientists, experts in business development and external advisors. The company is partnering with major insurance companies and main referral hospitals across the world, includin...

Main Line Health

Founded in 1985, Main Line Health (MLH) is a not-for-profit health system serving portions of Philadelphia and its western suburbs. At its core are four of the region’s respected acute care Hospitals — Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital — as well as one of the nation’s premier facilities for rehabil...

Elbion AG

elbion discovers and develops new small molecule drugs. Inflammatory and central nervous system diseases with high unmet medical need and high commercial potential are at the center of elbion's project pipeline, which covers all stages from early "hits" to advanced clinical projects.

NEUPOGEN® (Filgrastim)

NEUPOGEN® (Filgrastim) is Amgen’s first product indicated to decrease the incidence of infection (as manifested by febrile neutropenia)in certain cancer patients who are receiving chemotherapy.

Bio-xtal

The main objective of Bio-xtal is to develop high throughput tools in structural biology in order to provide productive value added services to pharmaceutical laboratories world wide. In order to achieve this goal, Bio-xtal is developing ambitious research programs involving a powerful academic network. The spirit of those programs is to join institution, industrial, academic and financial means t...

GeNO LLC

GeNO LLC, founded in 2006, is a privately held, advanced development-stage technology company that is developing innovative nitric oxide (NO) generation and delivery platforms to enable the true potential of inhaled nitric oxide to be realized. The company is focused on applying the new technology to deliver inhaled nitric oxide to patients in a wide variety of settings, including ambulatory and ...


More From BioPortfolio on "Amgen says Kyprolis Darzalex combination hits main goal"

Quick Search

Corporate Database Quicklinks